George Pankey, MD
- Sr Physician, Southshore Region
- 1514 Jefferson Hwy, New Orleans, LA, 70121
For additional information or to make an appointment, click here.
Overview
Overview
- Dr. Pankey earned his medical degree from Tulane and completed his internship and residency at the University of Minnesota where he also earned a masters degree in microbiology and immunology. He is board certified in Internal Medicine and infectious diseases and has been on staff at Ochsner since 1963. Dr. Pankey currently serves as chairman of the Institutional Biosafety Committee. He is a fellow of the Infectious Diseases Society of America and in 2001 was elected as Master of the American College of Physicians. Dr. Pankey is an internationally recognized and honored expert in the field of infectious diseases.
Publications
Selected publications
-
2023Whole-genome sequencing of carbapenem-resistant Enterobacterales isolates in southeast Louisiana reveals persistent genetic clusters spanning multiple locations. Journal of Infection and Public Health. 16:1911-1917.
-
2022IN VITRO INTERACTION OF LEFAMULIN, A PLEUROMUTILIN ANTIBIOTIC, AND DOXYCYCLINE AGAINST LINEZOLID- AND VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM. Journal of Investigative Medicine. 70:720-721.
-
2021Antimicrobial and resource utilization with T2 magnetic resonance for rapid diagnosis of bloodstream infections: systematic review with meta-analysis of controlled studies. Expert Review of Medical Devices. 18:473-482.
-
2020A PILOT STUDY OF THE IN VITRO INTERACTION OF FLUCONAZOLE AND TRIMETHOPRIM/SULFAMETHOXAZOLE AGAINST CANDIDA AURIS. Journal of Investigative Medicine. 68:690-690.
-
2020A PILOT STUDY OF THE IN VITRO INTERACTION OF FOSFOMYCIN AND MEROPENEM AGAINST METALL0-B-LACTAMASE PRODUCING PSEUDOMONAS AERUGINOSA USING ETEST AND TIME-KILL ASSAY. Journal of Investigative Medicine. 68:647-648.
-
2020In vitro synergy with fosfomycin plus doxycyclin against linezolid and vancomycin-resistant Enterococcus faecium. Journal of Global Antimicrobial Resistance. 22:78-83.
-
2020The T2Bacteria Assay Is a Sensitive and Rapid Detector of Bacteremia That Can Be Initiated in the Emergency Department and Has Potential to Favorably Influence Subsequent Therapy. The Journal of Emergency Medicine. 58:785-796.
-
2019IN VITRO SYNERGY OF FOSFOMYCIN PLUS DOXYCYCLINE AGAINST LINEZOLID AND VANCOMYCIN RESISTANT ENTEROCOCCUS FAECIUM USING A RAPID ETEST METHOD AND TIME-KILL ASSAY. Journal of Investigative Medicine. 67:597-597.
-
2019In vitro synergy with fluconazole plus doxycycline or tigecycline against clinical Candida glabrata isolates. Medical Mycology. 57:122-126.
-
2019PENTAMIDINE PLUS RIFAMPIN DEMONSTRATES IN VITRO SYNERGY AGAINST ENTEROBACTERIACEAE CARRYING THE MCR-1 GENE. Journal of Investigative Medicine. 67:596-597.
-
2019Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections A Diagnostic Accuracy Study. Annals of Internal Medicine. 170:845.
-
2019Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii. International Journal of Antimicrobial Agents. 53:663-668.
-
2018IN VITRO SYNERGISM OF FLUCONAZOLE PLUS POLYMYXIN B AGAINST CANDIDA AURIS. Journal of Investigative Medicine. 66:579-580.
-
2017Colistin and Polymyxin B Minimal Inhibitory Concentrations Determined by Etest Found Unreliable for Gram-Negative Bacilli. The Ochsner Journal. 17:239-242.
-
2017Evaluation of the Rapid Polymyxin NP Test for Polymyxin B Resistance Detection Using Enterobacter cloacae and Enterobacter aerogenes Isolates. Journal of Clinical Microbiology. 55:3016-3020.
-
2016In Vitro Synergistic Activity of Caspofungin Plus Plymyxin B Against Fluconazole-Resistant. The American Journal of the Medical Sciences. 351:265-270.
-
2015Detection of a New cfr-Like Gene, cfr(B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program. Antimicrobial Agents and Chemotherapy. 59:6256-6261.
-
2015IN VITRO SYNERGISTIC ACTIVITY OF CASPOFUNGIN AND POLYMYXIN B AGAINST FLUCONAZOLE-RESISTANT CANDIDA GLABRATA. Journal of Investigative Medicine. 63:472-472.
-
2015Update on the emerging role of telavancin in hospital-acquired infections. Therapeutics and Clinical Risk Management. 11:605-610.
-
2014Time-Kill Assay and Etest Evaluation for Synergy with Polymyxin B and Fluconazole against Candida glabrata. Antimicrobial Agents and Chemotherapy. 58:5795-5800.
-
2013Comparison of 3 Etest (R) methods and time-kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella species. Diagnostic Microbiology and Infectious Disease. 77:220-226.
-
2013In Vitro Synergy of Telavancin and Rifampin Against Enterococcus faecium Resistant to Both Linezolid and Vancomycin. The Ochsner Journal. 13:61-65.
-
2012Executive Summary: IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults. Clinical Infectious Diseases. 54:1041-1045.
-
2012IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults. Clinical Infectious Diseases. 54:E72-E112.
-
2011Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae. Diagnostic Microbiology and Infectious Disease. 70:561-564.
-
2010Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006 (vol 53, pg 4127, 2009). Antimicrobial Agents and Chemotherapy. 54:1383-1383.
-
2010In vitro synergistic/additive activity of levofloxacin with meropenem against Stenotrophomonas maltophilia. Diagnostic Microbiology and Infectious Disease. 67:297-300.
-
2009Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine US Medical Centers from 2002 to 2006. Antimicrobial Agents and Chemotherapy. 53:4127-4132.
-
2009In vitro antibacterial activity of tigecycline against resistant Gram-negative bacilli and enterococci by time-kill assay. Diagnostic Microbiology and Infectious Disease. 64:300-304.
-
2009Phaeohyphomycosis Infections in Solid Organ Transplant Recipients - The Largest Single Institution Experience. Laboratory Investigation. 89:294A-294A.
-
2009The detection of synergy between meropenem. and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest (R) and time-kill assay. Diagnostic Microbiology and Infectious Disease. 63:228-232.
-
2008IN VITRO ANTIBACTERIAL ACTIVITY OF TIGECYCLINE BY TIME-KILL ASSAY AGAINST LINEZOLID-SUSCEPTIBLE AND -RESISTANT VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM. American Journal of Tropical Medicine and Hygiene. 79:80-80.
-
2008In vitro testing of daptomycin plus rifampin against methicillin-resistant Staphylococcus aureus resistant to rifampin. Saudi Medical Journal. 29:1726-1729.
-
2008Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease. European Journal of Clinical Microbiology and Infectious Diseases. 27:937-943.
